The Biology and Treatment of Myeloid Leukaemias by Geoffrey BrownThe Biology and Treatment of Myeloid Leukaemias by Geoffrey Brown

The Biology and Treatment of Myeloid Leukaemias

Guest editorGeoffrey Brown, Ewa Marcinkowska

Paperback | April 16, 2018

Pricing and Purchase Info


Earn 362 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


There has been an observed decrease in the global mortality from cancer, mostly atributable to improved, particularly early, detection and prevention. For many carcinomas and leukaemias in adults, once the disease has reached a certain stage there are no therapies that are able to erradicate the cancer cells and cure patients. There has been progress in the treatment of acute myeloid leukaemia (AML) and remissions are achievable; however, the presence of chemoresistent blast cells leads to most patients relapsing, and relapse is difficult to treat and thus patients die due to their disease. Targeting these resistent cells and the leukaemia stem cells, which sustain the leukaemia, is crucial for an effective therapy for AML. Moreover, an increasing number of diverse mutations have been described in AML cells that disrupt the ability of these cells to undergo differentiation. The use of pro-differentiating agents to drive the blast cells to mature, and subsequently undergo apoptosis, provides another approach to therapy. Differentiation therapy, using all-trans retinoic acid (ATRA), an inducer of granulocyte differentiation, has been highly successful in the case of acute promyeloicytic leukaemia, a sub-type of AML, turning this disease into a curable malignancy.

Title:The Biology and Treatment of Myeloid LeukaemiasFormat:PaperbackProduct dimensions:198 pages, 9.61 × 6.69 × 0.54 inShipping dimensions:9.61 × 6.69 × 0.54 inPublished:April 16, 2018Publisher:MDPI AGLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3038427950

ISBN - 13:9783038427957